Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

Delayed Quote. Delayed  - 02/12 06:33:20 am
15.87 GBp   -3.08%
01/08 PROTEOME SCIENC : Director Dealing
2015 PROTEOME SCIENC : Gets Positive Results From CK1d Inhibitors Study
2015 PROTEOME SCIENC : Block Admission Return
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
17.5(c) 16.5(c) 16.625(c) 16.375(c) 15.87 Last
13 412 246 399 71 220 3 464 36 346 Volume
0.00% -5.71% +0.76% -1.50% -3.08% Change
More quotes
Financials ( GBP)
Sales 2015 2,08 M
EBIT 2015 -3,70 M
Net income 2015 -
Debt 2015 7,10 M
Yield 2015 -
Sales 2016 3,00 M
EBIT 2016 -3,20 M
Net income 2016 -
Debt 2016 9,40 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 21,4x
EV / Sales 2016 15,6x
Capitalization 37,3 M
More Financials
Company
Proteome Sciences Plc is a protein biomarker discovery service company, which specializes in proteomics and peptidomics services and applications, and a best-in-class mass spectrometry protein analysis capability.It offers sensitivity, proprietary technologies for protein and peptide biomarker... 
More about the company
Latest news on PROTEOME SCIENCES PLC
01/08 PROTEOME SCIENCES : Director Dealing
2015 PROTEOME SCIENCES : Gets Positive Results From CK1d Inhibitors Study
2015 PROTEOME SCIENCES : Block Admission Return
2015 PROTEOME SCIENCES : On Track For Strong Second Half Revenue As Loss Narrows
2015 PROTEOME SCIENCES : Unaudited Interim Results for the six months ended 30th June..
2015 PROTEOME SCIENCES : Appointment of Nominated Adviser and Broker
2015 PROTEOME SCIENCES : Expects Strong Revenue Growth On Good Pipeline
2015 PROTEOME SCIENCES : delivers ground-breaking programs with CK1d, SysQuant %7E TM..
More news
Sector news : Bio Therapeutic Drugs
02/11 LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02/11 FDA panel recommends approval for copy of arthritis drug Remicade
02/11 INCYTE : Nasdaq 100 Movers: INCY, TRIP
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Technical analysis trends PROTEOME SCIENCES...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials